Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIK
3126
DELISTED
Michaels Stores, Inc
MIK
| $1.56M | ﹤0.01% |
96,344
+60,617
| +170% | +$1.15M |
|
3127
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
| $1.56M | ﹤0.01% |
45,700
-6,800
| -13% | -$237K |
|
3128
PUT
PVH
PVH
$3.77B
| $1.56M | ﹤0.01% |
10,800
+8,000
| +286% | +$1.18M |
|
3129
PUT
Zions Bancorporation
ZION
$10.5B
| $1.56M | ﹤0.01% |
31,100
-37,700
| -55% | -$1.99M |
|
|
GBT
3130
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.56M | ﹤0.01% |
41,030
+35,736
| +675% | +$1.58M |
|
|
CKH
3131
DELISTED
Seacor Holdings Inc.
CKH
| $1.56M | ﹤0.01% |
31,544
+10,214
| +48% | +$529K |
|
3132
CALL
Zscaler
ZS
$30.4B
| $1.56M | ﹤0.01% |
+38,200
| New | +$1.54M |
|
3133
Open Text
OTEX
$6.02B
| $1.55M | ﹤0.01% |
40,849
-13,583
| -25% | -$519K |
|
|
XLRN
3134
DELISTED
Acceleron Pharma
XLRN
| $1.55M | ﹤0.01% |
27,183
-42,420
| -61% | -$2.08M |
|
3135
PUT
Danaher
DHR
$143B
| $1.55M | ﹤0.01% |
16,130
+4,399
| +37% | +$401K |
|
|
SAGE
3136
PUT
DELISTED
Sage Therapeutics
SAGE
| $1.55M | ﹤0.01% |
11,000
+6,000
| +120% | +$926K |
|
|
GNC
3137
DELISTED
GNC Holdings, Inc.
GNC
| $1.55M | ﹤0.01% |
375,610
+184,291
| +96% | +$610K |
|
3138
CALL
Enbridge
ENB
$112B
| $1.55M | ﹤0.01% |
48,100
-929,700
| -95% | -$32.5M |
|
3139
Rithm Capital
RITM
$5.79B
| $1.55M | ﹤0.01% |
87,054
-68,838
| -44% | -$1.26M |
|
3140
CALL
PACCAR
PCAR
$68.8B
| $1.55M | ﹤0.01% |
34,050
+14,100
| +71% | +$622K |
|
3141
PUT
Molina Healthcare
MOH
$10.7B
| $1.55M | ﹤0.01% |
10,400
+9,800
| +1,633% | +$1.25M |
|
|
NTRI
3142
DELISTED
NutriSystem, Inc.
NTRI
| $1.55M | ﹤0.01% |
41,738
+11,309
| +37% | +$437K |
|
|
GNBC
3143
DELISTED
Green Bancorp, Inc
GNBC
| $1.54M | ﹤0.01% |
69,927
+60,538
| +645% | +$1.42M |
|
3144
Central Garden & Pet Co Class A
CENTA
$2.41B
| $1.54M | ﹤0.01% |
58,156
+38,448
| +195% | +$1.17M |
|
|
SCS
3145
DELISTED
Steelcase
SCS
| $1.54M | ﹤0.01% |
83,390
+36,786
| +79% | +$540K |
|
3146
AngioDynamics
ANGO
$647M
| $1.54M | ﹤0.01% |
70,889
+26,627
| +60% | +$591K |
|
3147
CALL
Cal-Maine
CALM
$3.87B
| $1.54M | ﹤0.01% |
31,900
-4,600
| -13% | -$220K |
|
|
DNKN
3148
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.54M | ﹤0.01% |
20,900
+2,600
| +14% | +$188K |
|
3149
Atlantic Union Bankshares
AUB
$6.09B
| $1.54M | ﹤0.01% |
39,943
+28,010
| +235% | +$1.14M |
|
3150
Atlassian
TEAM
$42.1B
| $1.54M | ﹤0.01% |
16,026
+4,665
| +41% | +$369K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.